NFL: Texans RB Joe Mixon (ankle) to miss game vs. Jaguars

Date:

Share post:


Houston Texans running back Joe Mixon will miss his second consecutive game, inactive for Sunday’s home contest against the winless Jacksonville Jaguars.

The Texans (2-1) had listed Mixon as questionable because of a sprained ankle and he was limited in practice this week.

Mixon, 28, is the team’s leading rusher with 184 yards on 39 carries despite missing the Texans’ 34-7 loss to the Minnesota Vikings last week.

Mixon, who joined the Texans in the offseason after starring for the Cincinnati Bengals for seven seasons, sustained a sprained ankle against the Chicago Bears in Week 2.

Houston’s inactive list also includes running back Dameon Pierce, who is battling a hamstring injury, wide receiver Tank Dell, safety Jimmie Ward, linebacker Jamal Hill and guard Nick Broeker. Pierce, Dell (chest) and Ward (groin) already were ruled out on the final injury report.

The inactive players for Jacksonville (0-3): safety Darnell Savage, tight end Evan Engram, linebacker Devin Lloyd, defensive end Myles Cole, defensive tackle Jordan Jefferson, and offensive linemen Javon Foster and Cole Van Lanen. Savage (quad) and Lloyd (knee) were questionable, while Engram (hamstring) already was ruled out.

–Field Level Media

spot_img

Related articles

NCAAF: No. 24 UNLV shakes off slow start, tops San Jose State

Jai'Den Thomas ran for 135 yards and a touchdown to lead No. 24 UNLV over host San Jose...

NCAAF: Michigan State sends Purdue to 10th consecutive loss

Aidan Chiles completed 15 of 31 passes for 159 yards and two touchdowns to help Michigan State earn...

NCAAF: Iowa QB Cade McNamara slams ‘ridiculous’ rumors

Iowa quarterback Cade McNamara released a statement Friday slamming the "100% false" media reports that suggested he had...

NCAAF: Report: Iowa CB Jermari Harris opts out of rest of season

Iowa cornerback Jermari Harris has opted out of the remainder of the 2024 season in order to prepare...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.